Followers | 22 |
Posts | 3764 |
Boards Moderated | 0 |
Alias Born | 12/10/2020 |

Tuesday, April 29, 2025 2:23:38 PM
SESSION IV: Industry Blitz
Next Generation Dendritic Cell Treatments to Improve Anti-Tumor Responses
Marnix Bosch, PhD, Northwest Biotherapeutics Inc.
https://events.nyas.org/event/cbf0a499-91ad-45b2-bd87-c5a81fe38810/agenda?_gl=1*1bv4jyg*_gcl_au*MTMzOTQ4MTI3OC4xNzQ1OTQ1MjI2*_ga*MTkyNTUwODI3Ny4xNzQ1OTQ1MjI2*_ga_FL3407S79M*MTc0NTk0NTIyNS4xLjEuMTc0NTk0NTI1Ny4wLjAuNjU3NDc1MDc2*_fplc*ZnZoaE9wSW5iYnBHSU5JaGZKWUYlMkJOQVQ0WkZYTUFaelpCZE1reU5JOCUyRmg4OE1QSXBwU0lRbElYRHJsTkZBUHFzJTJGYzg1UEswcXowMGtCU2FHck5FaWp2U1hMR2dGenBFWW1vRkFpQlR4RU1Rck0lMkJ3SUI0U3IzZU1kb3RPcnclM0QlM0Q

Recent NWBO News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
- Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments • AllPennyStocks.com • 01/13/2025 01:56:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/26/2024 10:07:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:29:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:10:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 09:24:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM